(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with Sensitivity and Specificity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BC; Chen, P; Chen, X; Gillooly, KM; Hynes, J; Kiener, PA; Leftheris, K; McIntyre, KW; Norris, DJ; Pandit, C; Patil-Koota, V; Shuster, DJ; Turk, LA; Wu, H; Zhao, R | 1 |
1 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Sensitivity and Specificity
Article | Year |
---|---|
C-3 Amido-indole cannabinoid receptor modulators.
Topics: Amides; Animals; Anti-Inflammatory Agents; Cell Line; Humans; Immunity, Cellular; Indoles; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Protein Binding; Receptors, Cannabinoid; Receptors, Drug; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2002 |